A logo

Agilent Technologies (A) Company Overview

Profile

Full Name:

Agilent Technologies, Inc.

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

United States

IPO:

November 18, 1999

Indexes:

S&P 500

Website:

http://www.agilent.com

Description:

Agilent Technologies, Inc. was founded in 1999. The headquarters is located in California. The company offers applied solutions, which include instruments, software, services, and consumables for the entire laboratory workflow. The "Life Sciences and Applied Markets" business segment offers tools and software that allow customers to identify, quantify, and analyze the physical and biological properties of substances and products. The "Diagnostics and Genomics" business segment includes activities related to the production of reagents, pathogen research, companion diagnostics, gene studies, and preparation of nucleic acid solutions. The Agilent CrossLab business segment covers all laboratory activities.

Key Details

Price

$126.70

Market Cap

$36.12 B(Large cap)

Last Dividend

$0.25

TTM Dividend Yield

0.75%

Annual Revenue

$6.51 B(-4.73% YoY)

Annual EPS

$4.43(+5.73% YoY)

PE Ratio

29.13

Annual ROE

21.95%

Annual Debt To Equity

0.57

Beta

0.81

Events Calendar

Earnings

Next earnings date:

May 29, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Nov 25, 2024
Dividend

Next ex-dividend date:

Apr 1, 2025

Recent ex-dividend date:

Dec 31, 2024
Splits

Next split:

N/A

Recent split:

Nov 3, 2014

Analyst ratings

Recent major analysts updates

Feb 27, 25 Baird
Outperform
Feb 10, 25 Barclays
Equal-Weight
Jan 27, 25 B of A Securities
Neutral
Jan 10, 25 Bernstein
Market Perform
Dec 13, 24 B of A Securities
Neutral
Dec 9, 24 Wells Fargo
Overweight
Nov 27, 24 Barclays
Underweight
Nov 26, 24 JP Morgan
Overweight
Nov 26, 24 Evercore ISI Group
In-Line
Nov 26, 24 Bernstein
Market Perform

Screeners with A included

US stocks
S&P 500 companies earnings calendar
Stocks below SMA 200
Most recommended stocks
Best performing stocks last 5 years
S&P 500 companies
Stocks below analysts price target
S&P 500 companies dividend calendar
Healthcare sector
Companies with growing dividends

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$126.70
A price is $126.70

Price All-time High

$179.28
A price is currently -29.33% below its historical high of $179.28

Price Analysts Target

$153.00
A price is currently -17.19% lower than the consensus analysts' forecast

Price Most Recent Change

-0.24%
A price was down -0.24% on Mar 7, 2025

Price YTD Change

-5.69%
A price is down -5.69% since January 1st

Price 3-Year Change

-2.79%
A price is down -2.79% over the past 3 years

Market cap

Market Cap

$36.12 B
A market capitalization is $36.12 billion

Market Cap 3-Year Change

-7.65%
A market capitalization is down -7.65% over the past 3 years

Market Cap All-time High

$54.27 B
A market capitalization is currently -33.44% below its historical high of $54.27 billion

Market Cap Sector Rank

97.04%
A market capitalization is higher than 97.04% of companies in Healthcare sector

Technical

Beta

0.81
A beta is 0.81

200-day SMA

$137.63
A price is currently -7.94% below its 200-day simple moving average

14-day RSI

32.24
A 14-day relative strength index is 32.24

30-day Relative Volume

1.12
A 30-day relative volume is 1.12

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.25
A last dividend was $0.25 per share, with an ex-dividend date of December 31, 2024

Next Dividend

$0.25
A has announced a dividend of $0.25 per share, with an ex-dividend date set for April 1, 2025

Dividend per share

Annual Dividend Per Share

$0.94
A annual dividend per share is $0.94

Annual Dividend Per Share Sector Rank

40%
A annual dividend per share is higher than 40% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+4.89%
A annual dividend per share is up +4.89% year-on-year

Annual Dividend Per Share 3-Year Change

+21.65%
A annual dividend per share is up +21.65% over the past 3 years

Dividend yield

Annual Dividend Yield

0.75%
A annual dividend yield is 0.75%

Annual Dividend Yield Sector Rank

21.43%
A annual dividend yield is higher than 21.43% of companies in Healthcare sector

Other

Annual Payout Ratio

21.26%
A annual payout ratio is 21.26%

Annual Dividends Paid

$274.00 M
A annual dividends paid is $274.00 million

Annual FCF

$1.37 B
A annual free cash flow is $1.37 billion

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$6.51 B
A annual revenue is $6.51 billion

Annual Revenue Analysts Estimate

$6.74 B
A annual revenue is currently -3.44% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-4.73%
A annual revenue is down -4.73% year-on-year

Annual Revenue Sector Rank

92.75%
A annual revenue is higher than 92.75% of companies in Healthcare sector

Profit

Annual Gross Profit

$3.54 B
A annual gross profit is $3.54 billion

Annual Gross Margin

54.30%
A annual gross profit margin is 54.30%

Annual Operating Profit

$1.49 B
A annual operating income is $1.49 billion

Annual Operating Margin

22.86%
A annual operating profit margin is 22.86%

Annual Net Income

$1.29 B
A annual net profit is $1.29 billion

Annual Net Margin

19.80%
A annual net profit margin is 19.80%

EPS

Annual EPS

$4.43
A annual earnings per share is $4.43

Annual EPS Analysts Estimate

$5.57
A annual earnings per share is currently -20.48% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+5.73%
A annual earnings per share is up +5.73% year-on-year

Annual EPS Sector Rank

95.56%
A annual earnings per share is higher than 95.56% of companies in Healthcare sector

ROA & ROE

Annual ROA

11.40%
A annual return on assets is 11.40%

Annual ROE

21.95%
A annual return on equity is 21.95%

EBIT & EBITDA

Annual EBIT

$1.62 B
A annual earnings before interest & taxes is $1.62 billion

Annual EBITDA

$1.87 B
A annual EBITDA is $1.87 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

29.13
A price to earnings ratio is 29.13

PE Ratio Sector Rank

55.67%
A price to earnings ratio is higher than 55.67% of companies in Healthcare sector

PB Ratio

PB Ratio

5.99
A price to book ratio is 5.99

PB Ratio Sector Rank

85.91%
A price to book ratio is higher than 85.91% of companies in Healthcare sector

PS Ratio

PS Ratio

5.53
A price to sales ratio is 5.53

PS Ratio Sector Rank

66.49%
A price to sales ratio is higher than 66.49% of companies in Healthcare sector

Enterprise value

Enterprise Value

$38.02 B
A enterprise value is $38.02 billion

Enterprise Value Sector Rank

96.85%
A enterprise value is higher than 96.85% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

20.51
A EV/EBITDA is 20.51

EV/EBITDA Sector Rank

91.16%
A EV/EBITDA is higher than 91.16% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.09
A annual current ratio is 2.09

Annual Quick Ratio

1.58
A annual quick ratio is 1.58

Leverage

Annual Debt To Equity

0.57
A annual debt to equity ratio is 0.57

Annual Interest Coverage Ratio

16.84
A annual interest coverage ratio is 16.84

Risk & Stability

Piotroski F-Score

5
A piotroski f-score is 5

Altman Z-Score

4.94
A altman z-score is 4.94

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$11.85 B
A annual total assets is $11.85 billion

Annual Non Current Assets

$7.89 B
A annual long term assets is $7.89 billion

Annual Current Assets

$3.96 B
A annual total current assets is $3.96 billion

Annual Cash & Cash Equivalents

$1.33 B
A annual cash & cash equivalents is $1.33 billion

Equity

Annual Book Value

$5.90 B
A annual book value is $5.90 billion

Annual Working Capital

$2.06 B
A annual working capital is $2.06 billion

Liabilities

Annual Total Liabilities

$5.95 B
A annual total liabilities is $5.95 billion

Annual Total Long Term Liabilities

$4.05 B
A annual total long term liabilities is $4.05 billion

Annual Current Liabilities

$1.90 B
A annual total current liabilities is $1.90 billion

Annual Accounts Payable

$540.00 M
A annual accounts payable is $540.00 million

Debt

Annual Total Debt

$3.39 B
A annual total debt is $3.39 billion

Annual Total Debt 1-Year Change

+23.95%
A annual total debt is up +23.95% year-on-year

Annual Long Term Debt

$3.35 B
A annual long term debt is $3.35 billion

Annual Short Term Debt

$45.00 M
A annual short term debt is $45.00 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$5.02 B
A annual total expenses is $5.02 billion

Annual Operating Expenses

$2.05 B
A annual total operating expenses is $2.05 billion

Annual Cost Of Goods Sold

$2.98 B
A annual cost of goods sold is $2.98 billion

Annual SGA

$1.57 B
A annual SGA is $1.57 billion

Annual D&A

$257.00 M
A annual depreciation & amortization is $257.00 million

Annual Interest Expense

$96.00 M
A annual interest expense is $96.00 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$1.75 B
A annual cash flow from operations is $1.75 billion

Annual CFO 1-Year Change

-1.19%
A annual cash flow from operations is down -1.19% year-on-year

Annual CFI

-$1.26 B
A annual cash flow from investing activities is -$1.26 billion

Annual CFI 1-Year Change

-305.81%
A annual cash flow from investing activities is down -305.81% year-on-year

Annual CFF

-$752.00 M
A annual cash flow from financing activities is -$752.00 million

Annual CFF 1-Year Change

+19.14%
A annual cash flow from financing activities is up +19.14% year-on-year

Free CashFlow

Annual FCF

$1.37 B
A annual free cash flow is $1.37 billion

Annual FCF 1-Year Change

-6.85%
A annual free cash flow is down -6.85% year-on-year

CAPEX

Annual CAPEX

$378.00 M
A annual capital expenditures is $378.00 million

Annual CAPEX 1-Year Change

+26.85%
A annual capital expenditures is up +26.85% year-on-year

Institutional Ownership

Similar stocks

ARGX logo
argenx SE (ARGX)
IDXX logo
IDEXX Laboratories (IDXX)
RMD logo
ResMed (RMD)
IQV logo
IQVIA Holdings (IQV)
GEHC logo
GE HealthCare Technologies (GEHC)
VEEV logo
Veeva Systems (VEEV)
ALNY logo
Alnylam Pharmaceuticals (ALNY)
HUM logo
Humana (HUM)
EW logo
Edwards Lifesciences (EW)

FAQ

  • What is the ticker symbol for Agilent Technologies?
  • Does Agilent Technologies pay dividends?
  • What sector is Agilent Technologies in?
  • What industry is Agilent Technologies in?
  • What country is Agilent Technologies based in?
  • When did Agilent Technologies go public?
  • Is Agilent Technologies in the S&P 500?
  • Is Agilent Technologies in the NASDAQ 100?
  • Is Agilent Technologies in the Dow Jones?
  • When was Agilent Technologies's last earnings report?
  • When does Agilent Technologies report earnings?
  • Should I buy Agilent Technologies stock now?

What is the ticker symbol for Agilent Technologies?

The ticker symbol for Agilent Technologies is NYSE:A

Does Agilent Technologies pay dividends?

Yes, Agilent Technologies pays dividends. The last payment was $0.25, with an ex-dividend date on December 31, 2024

What sector is Agilent Technologies in?

Agilent Technologies is in the Healthcare sector

What industry is Agilent Technologies in?

Agilent Technologies is in the Diagnostics & Research industry

What country is Agilent Technologies based in?

Agilent Technologies is headquartered in United States

When did Agilent Technologies go public?

Agilent Technologies's initial public offering (IPO) was on November 18, 1999

Is Agilent Technologies in the S&P 500?

Yes, Agilent Technologies is included in the S&P 500 index

Is Agilent Technologies in the NASDAQ 100?

No, Agilent Technologies is not included in the NASDAQ 100 index

Is Agilent Technologies in the Dow Jones?

No, Agilent Technologies is not included in the Dow Jones index

When was Agilent Technologies's last earnings report?

Agilent Technologies's most recent earnings report was on Feb 26, 2025

When does Agilent Technologies report earnings?

The next expected earnings date for Agilent Technologies is May 29, 2025

Should I buy Agilent Technologies stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions